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The recent study by Bloos and colleagues
demonstrates that early initiation of antimicrobial
therapy is not associated with improved survival in
sepsis. We contend that these findings should not be
surprising. This study is yet another part of the
growing case against early and aggressive
antimicrobial therapy and highlights the important
roles resuscitation and source control play in the
management of the septic patient. We suggest that,
whenever possible, antimicrobial therapy should we
withheld until objective evidence of infection has
been obtained.colleagues [2] that suggests that timely administration ofBloos and colleagues [1] present the results of a large,
prospective, multicenter, cohort study of patients in se-
vere sepsis or septic shock. The authors evaluated 1,011
medical and surgical patients. They identified that, in all
cases, delay of antimicrobial therapy of more than 1 hour
was not independently associated with mortality. In the
surgical cohort, a delay in source control greater than
6 hours was significantly associated with mortality. For
the combined cohort, inappropriate therapy was also as-
sociated with mortality on multivariate analysis. These
results are compelling and go against conventional wis-
dom on this subject.
In studies of this type it is often difficult to discern the
true time of infection. This study is no different. The au-
thors have chosen to use the time of first infection-related
organ dysfunction. While we appreciate its objective na-
ture, this definition presents a two-fold problem. Firstly,
57.4 % of patients developed sepsis in the ICU. Presumably,
most ICU patients were there in the first place because of
some underlying organ dysfunction. It may not be* Correspondence: rws2k@virginia.edu
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2014immediately apparent that this dysfunction is infection-
related, making this a definition that can only be applied
retrospectively. For example, how did the authors handle
ventilator-associated pneumonia, where patients by defin-
ition already had failure of one organ system? Secondly,
13.9% of patients 'developed' sepsis in the emergency de-
partment. Therefore, the time until initiation of therapy is
more indicative of the time from arrival until recognition
of sepsis than the true time from onset of organ dysfunc-
tion. These patients were likely suffering organ dysfunction
upon arrival to the emergency department. It would be in-
teresting to see the results with these patients excluded.
Should these findings have been surprising? We think
not. The author’s cite a meta-analysis by Barochia and
antimicrobials is associated with improved survival.
However, this finding was only significant after removing
the effects from Rivers and colleagues’ study on early
goal-directed therapy [3]. Another meta-analysis con-
ducted on studies of outpatient respiratory infections
found no difference between immediate or delayed anti-
biotic therapy [4]. Puskarich and colleagues [5] demon-
strated that, in the setting of appropriate resuscitation,
the timing of antimicrobial therapy appears to have little
effect on mortality. Similarly, Hranjec and colleagues [6]
found that, assuming resuscitation and source control
occur in a timely manner, intentionally withholding anti-
microbial therapy until infection can be objectively
proven to result in improved patient outcomes com-
pared with early and aggressive initiation. These studies
focused on emergency department and ICU manage-
ment, respectively. Bloos and colleagues’ study confirms
the findings of Hranjec and colleagues and Puskarich
and colleagues, while spanning the entire spectrum of
hospitalization.
This trial also suffers from the most common deficit
in most studies of timing of antimicrobial therapy in pa-
tients with severe sepsis or septic shock: the lack of a
proper control group. The question faced by the clin-
ician is not whether a patient with proven infection
should have the rapid initiation of antimicrobials, butentral Ltd. The licensee has exclusive rights to distribute this article, in any
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therapy. Missing in this study is the group of patients
who received antimicrobials for suspected infection but
were not infected, and what the consequences of this
unnecessary exposure to antibiotics were. However, the
data are reassuring to us who believe that it is prudent
to wait until there is objective microbiological data to
support the diagnosis of infection before initiating ther-
apy. Even among these patients with significant disease,
the exact timing of antimicrobial therapy did not appear
to be the main driver of outcomes.
At its core, the narrow-focused debate surrounding
the timing of antimicrobial therapy is inherently flawed.
The appropriate treatment of the septic patient requires
a rapid multimodal response including fluid resuscita-
tion, source control, and pressors (if required). Antimi-
crobials are only one part of this equation. In cases of
life threatening septic shock, broad-spectrum empiric
therapy should be initiated as soon as possible. However,
the harmful effects of inappropriate antimicrobials
should be mitigated, whenever possible, by using
culture-guided therapy and delayed initiation. In all
cases, resuscitation and source control should be the
highest priority. Bloos and colleagues’ study is a re-
minder that antimicrobials, while important, are not the
only tools in our arsenal against infectious disease.
Conclusion
Overall, Bloos and colleagues have provided another in-
teresting wrinkle in the story of antimicrobials and sep-
sis. Their study is well executed and practical, and the
authors are to be commended for their excellent work.
We look forward to the results of their randomized trial.
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